News
At the second annual HLTH Europe event in Amsterdam, Deep Dive editor Eloise McLennan sat down with ABIG Health founder and ...
Biogen says it is the first drugmaker in the US to get FDA approval for a biosimilar of Roche’s $3 billion blockbuster product Actemra. The intravenous biosimilar of IL-6 inhibitor Actemra ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback